Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co-administered enteric-coated mycophenolate sodium

: Enteric‐coated mycophenolate sodium (EC‐MPS) (myfortic®) is an advanced formulation delivering mycophenolic acid (MPA), designed to improve MPA‐related upper gastrointestinal adverse events by delaying the release of MPA until the small intestine. A randomized, calcineurin inhibitor crossover, st...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical transplantation 2005-08, Vol.19 (4), p.551-558
Hauptverfasser:	Kaplan, Bruce, Meier-Kriesche, Herwig-Ulf, Minnick, Paula, Bastien, Marie-Claude, Sechaud, Romain, Yeh, Ching-Ming, Balez, Sebastien, Picard, Franck, Schmouder, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Blood Glucose - analysis Calcineurin Inhibitors Cardiology. Vascular system Cross-Over Studies Cyclosporine - pharmacokinetics cyclosporine microemulsion Emulsions enteric-coated mycophenolate sodium Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - pharmacokinetics Female Humans Kidney Transplantation Male Medical sciences Middle Aged Mycophenolic Acid - administration & dosage Mycophenolic Acid - pharmacokinetics myfortic Nephrology. Urinary tract diseases pharmacokinetics Sodium - administration & dosage Tablets, Enteric-Coated tacrolimus Tacrolimus - pharmacokinetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!